Penny Stocks Icon

Penny Stocks

Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.

Recent Penny Stocks Articles

Why Is American Rebel (AREB) Stock Up 40% Today?

American Rebel (AREB) stock is taking off on Thursday as investors react to news of Liberty Safe providing access codes to the FBI.

Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?

China SXT Pharmaceuticals (SXTC) stock is heading higher on Thursday even without any news from the pharmaceutical company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!

Why Is Digital Brands (DBGI) Stock Down 15% Today?

Digital Brands (DBGI) stock is dropping on Wednesday after the women's apparel company announced a Securities Purchase Agreement.

Why Is Verb Technology (VERB) Stock Down 24% Today?

Verb Technology (VERB) stock is retreating on Wednesday after the software-as-a-service company went through a massive rally on Tuesday!

Why Is Marin Software (MRIN) Stock Up 34% Today?

Marin Software (MRIN) stock is rising higher on Wednesday after the marketing software company announced the integration of HubSpot data.

Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?

NeuBase Therapeutics (NBSE) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company.

Today Is the Last Day for Mullen (MULN) Stock to Regain Nasdaq Compliance

MULN stock has failed to close at or above $1 for at least 10, but generally no more than 20, consecutive business days before Sept. 5.

MULN Stock Alert: Charles Payne Questions David Michery Over Mullen

Mullen CEO David Michery was interviewed by Fox Business host Charles Payne. Here's what MULN stock investors need to know.

Why Is 1847 Holdings (EFSH) Stock Down 19% Today?

1847 Holdings (EFSH) stock is taking a beating on Tuesday after the company received a delisting notice from the NYSE American LLC.

Why Is TradeUP Acquisition (UPTD) Stock Down 33% Today?

TradeUP Acquisition (UPTD) stock is falling on Tuesday as the company's shares give up gains seen during a recent rally.

Why Is Crown ElectroKinetics (CRKN) Stock Up 15% Today?

Crown ElectroKinetics (CRKN) stock is on the rise Tuesday after the company revealed plans for an investor conference call.

Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?

Helius Medical Technologies (HSDT) stock is rising higher on Tuesday as investors react to the company regaining listing compliance.

Forget AI Mania! 3 Penny Stocks With Serious Upside Potential

These penny stocks offer tremendous upside potential with minimal risk, unlike many of the stocks impacted by the AI mania.

The 3 Best Momentum Stocks to Buy Now: September 2023

These momentum stocks have been growing their businesses substantially in recent months, and Wall Street is rewarding them accordingly.

3 Penny Stocks That Can Triple Your Money in the Next 12 Months

Although penny stocks are among the most speculative asset classes, these wagers just happen to have strong analyst backing.

Knightscope (KSCP) Stock Pops 3% on New 7-Robot Contract

While Knightscope is risky, its recent contract with a pharma company highlights the security robotics potential underlying KSCP stock.

GNS Stock Alert: Today Is the Record Date for the Genius Group Spinoff

The record date for the GNS stock spinoff of Entrepreneur Resorts Ltd is today. Here's what you need to know.

Why Is Axcella Health (AXLA) Stock Down 21% Today?

Axcella Health (AXLA) stock is falling on Thursday following a rally from its announcement of a new Covid-19 treatment patent.